Abbrea Capital LLC lowered its holdings in Morgan Stanley (NYSE:MS) by 8.0% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 14,783 shares of the financial services provider’s stock after selling 1,282 shares during the quarter. Abbrea Capital LLC’s holdings in Morgan Stanley were worth $688,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Tiedemann Advisors LLC lifted its stake in shares of Morgan Stanley by 8.7% in the 2nd quarter. Tiedemann Advisors LLC now owns 14,198 shares of the financial services provider’s stock valued at $674,000 after purchasing an additional 1,135 shares during the period. GWM Advisors LLC increased its position in Morgan Stanley by 12.2% during the 3rd quarter. GWM Advisors LLC now owns 10,883 shares of the financial services provider’s stock valued at $507,000 after buying an additional 1,184 shares in the last quarter. Sawtooth Solutions LLC increased its position in Morgan Stanley by 25.3% during the 3rd quarter. Sawtooth Solutions LLC now owns 5,957 shares of the financial services provider’s stock valued at $277,000 after buying an additional 1,201 shares in the last quarter. Appleton Partners Inc. MA increased its position in Morgan Stanley by 4.4% during the 3rd quarter. Appleton Partners Inc. MA now owns 29,085 shares of the financial services provider’s stock valued at $1,354,000 after buying an additional 1,220 shares in the last quarter. Finally, Cornerstone Advisors Inc. increased its position in Morgan Stanley by 33.4% during the 2nd quarter. Cornerstone Advisors Inc. now owns 4,894 shares of the financial services provider’s stock valued at $232,000 after buying an additional 1,224 shares in the last quarter. Institutional investors and hedge funds own 84.87% of the company’s stock.

MS has been the subject of a number of analyst reports. Wolfe Research initiated coverage on Morgan Stanley in a research report on Tuesday, September 25th. They set an “outperform” rating for the company. Vining Sparks reaffirmed a “buy” rating and set a $60.00 price objective on shares of Morgan Stanley in a research report on Tuesday, October 16th. ValuEngine lowered Morgan Stanley from a “hold” rating to a “sell” rating in a research report on Thursday, August 2nd. Zacks Investment Research raised Morgan Stanley from a “hold” rating to a “buy” rating and set a $50.00 price objective for the company in a research report on Tuesday. Finally, Oppenheimer raised Morgan Stanley to an “outperform” rating and set a $62.00 price objective for the company in a research report on Tuesday, October 16th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and eleven have given a buy rating to the stock. Morgan Stanley currently has a consensus rating of “Buy” and a consensus price target of $58.47.

In other Morgan Stanley news, major shareholder Stanley Morgan sold 327 shares of Morgan Stanley stock in a transaction on Wednesday, September 19th. The stock was sold at an average price of $23,000.00, for a total value of $7,521,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.19% of the stock is currently owned by company insiders.

Morgan Stanley stock opened at $43.73 on Thursday. The firm has a market capitalization of $76.39 billion, a price-to-earnings ratio of 12.15, a price-to-earnings-growth ratio of 0.77 and a beta of 1.28. Morgan Stanley has a 12 month low of $42.54 and a 12 month high of $59.38. The company has a debt-to-equity ratio of 2.67, a current ratio of 0.80 and a quick ratio of 0.80.

Morgan Stanley (NYSE:MS) last posted its earnings results on Tuesday, October 16th. The financial services provider reported $1.17 EPS for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.16. The business had revenue of $9.87 billion during the quarter, compared to analyst estimates of $9.55 billion. Morgan Stanley had a return on equity of 12.51% and a net margin of 15.93%. The company’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the company earned $0.93 EPS. Equities research analysts forecast that Morgan Stanley will post 4.94 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 15th. Shareholders of record on Wednesday, October 31st were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 2.74%. The ex-dividend date of this dividend was Tuesday, October 30th. Morgan Stanley’s payout ratio is 33.33%.

COPYRIGHT VIOLATION NOTICE: “Morgan Stanley (MS) Shares Sold by Abbrea Capital LLC” was reported by Daily Political and is owned by of Daily Political. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2018/11/22/morgan-stanley-ms-shares-sold-by-abbrea-capital-llc.html.

Morgan Stanley Company Profile

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company operates Institutional Securities, Wealth Management, and Investment Management segments.

Featured Article: Day Trading

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.